JB Chemicals (India) Performance
| JBCHEPHARM | 1,746 24.00 1.39% |
The firm owns a Beta (Systematic Risk) of -0.023, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning JB Chemicals are expected to decrease at a much lower rate. During the bear market, JB Chemicals is likely to outperform the market. At this point, JB Chemicals Pharmac has a negative expected return of -0.0805%. Please make sure to check out JB Chemicals' potential upside, day median price, and the relationship between the treynor ratio and accumulation distribution , to decide if JB Chemicals Pharmac performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days JB Chemicals Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, JB Chemicals is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders. ...more
Forward Dividend Yield 0.0078 | Payout Ratio 0.3167 | Last Split Factor 2:1 | Forward Dividend Rate 13.5 | Ex Dividend Date 2024-08-14 |
1 | J B Chemicals Pharmaceuticals Stock Declines -3.04 percent Amidst Sector Underperformance - MarketsMojo | 11/13/2024 |
2 | J B Chemicals Pharmaceuticals Receives Upgraded Stock Call from MarketsMOJO - MarketsMojo | 12/02/2024 |
3 | Is J. B. Chemicals Pharmaceuticals Limiteds Recent Stock Performance Tethered To Its Strong Fundamentals - Simply Wall St | 12/23/2024 |
4 | J B Chemicals Pharmaceuticals Stock Gains 3.03 percent Amid Market Fluctuations - MarketsMojo | 01/07/2025 |
5 | J. B. Chemicals Pharmaceuticals investors will be pleased with their incredible 712 percent return over the last five years - Simply Wall St | 01/10/2025 |
6 | J B Chemicals Pharmaceuticals Faces Continued Decline Amid Broader Market Gains - MarketsMojo | 01/27/2025 |
| Begin Period Cash Flow | 769.3 M |
JBCHEPHARM |
JB Chemicals Relative Risk vs. Return Landscape
If you would invest 184,900 in JB Chemicals Pharmaceuticals on November 2, 2024 and sell it today you would lose (10,300) from holding JB Chemicals Pharmaceuticals or give up 5.57% of portfolio value over 90 days. JB Chemicals Pharmaceuticals is generating negative expected returns and assumes 1.7446% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than JBCHEPHARM, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
JB Chemicals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for JB Chemicals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as JB Chemicals Pharmaceuticals, and traders can use it to determine the average amount a JB Chemicals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0461
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | JBCHEPHARM |
Estimated Market Risk
| 1.74 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average JB Chemicals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of JB Chemicals by adding JB Chemicals to a well-diversified portfolio.
JB Chemicals Fundamentals Growth
JBCHEPHARM Stock prices reflect investors' perceptions of the future prospects and financial health of JB Chemicals, and JB Chemicals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on JBCHEPHARM Stock performance.
| Return On Equity | 0.21 | ||||
| Return On Asset | 0.13 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 264.28 B | ||||
| Shares Outstanding | 155.61 M | ||||
| Price To Book | 8.33 X | ||||
| Price To Sales | 7.32 X | ||||
| Revenue | 34.48 B | ||||
| Gross Profit | 24.27 B | ||||
| EBITDA | 9.33 B | ||||
| Net Income | 5.53 B | ||||
| Cash And Equivalents | 269.12 M | ||||
| Total Debt | 3.78 B | ||||
| Book Value Per Share | 206.82 X | ||||
| Cash Flow From Operations | 8.01 B | ||||
| Earnings Per Share | 38.35 X | ||||
| Total Asset | 39.94 B | ||||
| Retained Earnings | 25.13 B | ||||
About JB Chemicals Performance
By evaluating JB Chemicals' fundamental ratios, stakeholders can gain valuable insights into JB Chemicals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if JB Chemicals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if JB Chemicals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
JB Chemicals is entity of India. It is traded as Stock on NSE exchange.Things to note about JB Chemicals Pharmac performance evaluation
Checking the ongoing alerts about JB Chemicals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for JB Chemicals Pharmac help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| JB Chemicals Pharmac generated a negative expected return over the last 90 days | |
| JB Chemicals Pharmac is unlikely to experience financial distress in the next 2 years | |
| About 54.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: J B Chemicals Pharmaceuticals Faces Continued Decline Amid Broader Market Gains - MarketsMojo |
- Analyzing JB Chemicals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether JB Chemicals' stock is overvalued or undervalued compared to its peers.
- Examining JB Chemicals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating JB Chemicals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of JB Chemicals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of JB Chemicals' stock. These opinions can provide insight into JB Chemicals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for JBCHEPHARM Stock analysis
When running JB Chemicals' price analysis, check to measure JB Chemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JB Chemicals is operating at the current time. Most of JB Chemicals' value examination focuses on studying past and present price action to predict the probability of JB Chemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move JB Chemicals' price. Additionally, you may evaluate how the addition of JB Chemicals to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |